Cetera Investment Advisers’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Cetera Investment Advisers’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.25M	Sell	49,004 -8,319	-15%	-$487K	﹤0.01%	1960
2026 Q1	$3.1M	Sell	57,323 -23,655	-29%	-$1.32M	﹤0.01%	1872
2025 Q4	$4.54M	Buy	80,978 +11,683	+17%	+$605K	0.01%	1525
2025 Q3	$3.32M	Buy	69,295 +62,706	+952%	+$2.8M	﹤0.01%	1739
2025 Q2	$267K	Sell	6,589 -40	-0.6%	-$1.61K	﹤0.01%	3493
2025 Q1	$290K	Sell	6,629 -1,000	-13%	-$44.1K	﹤0.01%	3291
2024 Q4	$328K	Sell	7,629 -718	-9%	-$32.6K	﹤0.01%	3038
2024 Q3	$370K	Sell	8,347 -419	-5%	-$17.9K	﹤0.01%	2890
2024 Q2	$349K	Sell	8,766 -858	-9%	-$34.8K	﹤0.01%	2905
2024 Q1	$415K	Buy	+9,624	New	+$415K	﹤0.01%	2762
2020 Q2	–	Sell	-11,100	Closed	-$400K	–	634
2020 Q1	$400K	Buy	+11,100	New	+$473K	0.05%	341

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Cetera Investment Advisers's XPH Position: Q2 2026 in Review

Cetera Investment Advisers reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 15% in Q2 2026, selling an estimated $487K and leaving 49,004 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1960.

Cetera Investment Advisers first reported a position in XPH in Q1 2020 and has held it in 11 quarters since. The position peaked at $4.54M in Q4 2025. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Cetera Investment Advisers held 49,004 shares of State Street SPDR S&P Pharmaceuticals ETF worth $3.25M as of Q2 2026.
Cetera Investment Advisers sold 8,319 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $487K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1960 holding.
Cetera Investment Advisers first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2020 and has held it in 11 quarters since.
Cetera Investment Advisers's State Street SPDR S&P Pharmaceuticals ETF position peaked at $4.54M in Q4 2025.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.